HCA · NYSE · Medical - Care Facilities

HCA Healthcare (HCA)

Operator of hospital-anchored care networks spanning inpatient, outpatient, emergency, and physician services.

$434.71
vs last close+8.74 (+2.05%)
Loading prices…

HCA Healthcare, Inc.HCA
Health Care

Provides inpatient and outpatient care through acute-care, behavioral, and rehabilitation hospitals; surgery centers; emergency and urgent care sites; physician practices; and home-based services. Patient-service revenue is paid mainly by insurers and government programs, with the network concentrated in Florida and Texas and supported by enterprise-scale clinical and operating systems.

Operates 190 hospitals and a broad outpatient network across the United States and England. General acute-care hospitals anchor the system, supported by behavioral and rehabilitation hospitals, ambulatory surgery and endoscopy centers, freestanding emergency rooms, urgent care sites, physician practices, home health agencies, and hospices.

Builds comprehensive local care networks, then supports them with centralized clinical data, patient transfers, workforce development, and enterprise scale. Revenue comes from patient services reimbursed by managed-care and commercial insurers, Medicare, Medicaid, and patients. Payment rates, insurer contracts, health-care regulation, and clinician availability shape operations, while Florida and Texas generate roughly half of revenue.

Company facts

CEOSamuel N. Hazen
ListedMar 10, 2011
ExchangeNYSE
HeadquartersNashville, TN
CountryUnited States
Employees320,000
CIK0000860730
ISINUS40412C1018

Market cap$92.22B
EPS (ttm)$29.87
P/E (ttm)14.26
ROE
P/B
P/S1.18
Dividend yieldDiv yield0.72%
Beta0.16vs XLV 0.62

Price target$442.50+3.9%Average of 46 analysts
ConsensusBuy29 of 46 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Jul 28, 2026Goldman SachsReiterate
Rating: Target: $520
Rating: BuyTarget: $485
Jul 27, 2026UBSReiterate
Rating: Target: $635
Rating: BuyTarget: $579
Jul 27, 2026Deutsche BankTarget
Target: $441
Target: $476
Jul 27, 2026Morgan StanleyReiterate
Rating: Target: $425
Rating: UnderweightTarget: $380
Jul 27, 2026OppenheimerReiterate
Rating: Target: $520
Rating: OutperformTarget: $485

Next report
Oct 23, 26
in 31 days
EPS estimate
$6.70
Revenue estimate
$19.35B
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Reported$6.22$6.45$6.84$6.96$8.01$7.15$7.59Pending
Estimate$6.13$5.75$6.29$5.79$7.46$7.12$7.56$6.70
Surprise+1.5%+12.2%+8.7%+20.2%+7.4%+0.4%+0.4%

RevenueReportedEstimate

Jan '25Apr '25Jul '25Oct '25Jan '26Apr '26Jul '26Oct '26
Reported$18.29B$18.32B$18.61B$19.16B$19.51B$19.11B$20.23BPending
Estimate$18.23B$18.26B$18.50B$18.60B$19.68B$19.09B$19.76B$19.35B
Surprise+0.3%+0.3%+0.6%+3.0%−0.9%+0.1%+2.4%
Estimate$6.70
ReportedDue Oct 23, 2026
Estimate$19.35B
ReportedDue Oct 23, 2026
View details

Current ratio78.10%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$17.49B$18.29B$18.32B$18.61B$19.16B$19.51B$19.11B$20.23B
Net income$1.27B$1.44B$1.61B$1.65B$1.64B$1.88B$1.62B$1.70B
Net margin7.3%7.9%8.8%8.9%8.6%9.6%8.5%8.4%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$2.41B$2.85B$2.86B$2.97B$2.97B$3.18B$2.86B$3.07B
YoY growthTurned profit+1.6%+11.5%+8.6%+23.0%+11.7%+0.3%+3.4%

Balance sheet, Jun 30, 2026Cash & short-term investments $1.01B · Total debt $48.78B · Total assets $60.53B · Shareholders' equity −$6.58B

Revenue
$20.23B
Operating income
$3.07B
Net income
$1.70B
View details

Dividend yield
0.72%
Next ex-date
Dec 16, 26
estimated · in 85 days
Annual dividend
$3.06
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26Sep '26
Dividend$0.66$0.72$0.72$0.72$0.72$0.78$0.78$0.78
Annual yield0.84%0.82%0.75%0.71%0.60%0.58%0.76%0.71%
Ex-dateDec 13Mar 17Jun 16Sep 16Dec 15Mar 17Jun 16Sep 16
Payment dateDec 27Mar 31Jun 30Sep 30Dec 29Mar 31Jun 30Sep 30
View details

Institutions61.17%132.43M shares
1,398 holders · as of Jun 30, 2026
Insiders17.16%37.16M shares
22 holders · as of Sep 11, 2026
Strategic holders14.91%32.28M shares
1 holder · as of Feb 10, 2026
Other6.76%14.63M shares
remainder

216.50M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Thomas F. Iii FristInsiderdirector, 10 percent owner
16.89%36.57Mfiled Apr 30, 2026
Hercules Holding IiStrategic10 percent owner
14.91%32.28Mfiled Feb 10, 2026
BlackRock, Inc.Institution
6.01%13.00Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
4.68%10.14Mas of Jun 30, 2026
Sanders Capital, LLCInstitution
4.08%8.83Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Feb 18, 2026Michael R. McAleveyofficer: EVP & Chief Legal & Admin Off.−1,694$533.37
Feb 11, 2026Jennifer Berresofficer: SVP & Chief Human Res. Officer−8,020$514.58
Feb 11, 2026Christopher F. Wyattofficer: SVP & Controller−4,000$505.00
Feb 3, 2026Michael S. Cuffeofficer: EVP and Chief Clinical Officer−1,500$498.09
Feb 3, 2026Samuel N. Hazendirector, officer: CEO−42,877$501.04
View details

  • Tenet Healthcare

    Acute-care hospitals and the largest ASC chain (USPI) in overlapping Sun Belt markets.

  • Universal Health Services

    Acute-care hospitals and dominant US behavioral health network in overlapping markets.

  • Community Health Systems

    Rural and suburban acute-care hospital operator in overlapping Sun Belt markets.

  • Encompass Health

    Nation's largest inpatient rehabilitation hospital chain; competes for post-acute referrals.

  • Surgery Partners

    Pure-play ASC operator competing for outpatient surgical volume in overlapping markets.

Compare

CompanyPriceChange
HCA Healthcare$434.71+2.05%$92.22B14.314.21.2+8.7%
Tenet Healthcare$262.69+0.66%$21.01B10.112.61.0+6.8%
Universal Health Services$178.93+2.40%$10.58B7.27.80.6+8.3%
Community Health Systems$2.97+2.60%$407.5M0.0−9.8%
Encompass Health$123.36+1.48%$12.06B19.819.31.9+9.6%
Surgery Partners$14.14+3.48%$1.79B32.90.5+2.8%
Median10.115.90.6+6.8%